Study records Selection process
Include reviewers' initials in the narrative, eg, 'merging of the results of the database searches will be done and two independently working researchers (AAK and EDD)' There is no mention of a full-text screening form (which should be available) to enable readers to see the criteria used in selecting studies How many independent researchers are going to be merging the results from the database searches? How are disagreements and other issues pertaining to the screening process going to be resolved? There is need for a third independent reviewer will mediate the discussions Dates and related activities This work plan is not necessary to be included in the manuscript. I suggest the authors remove it Risk of bias and quality assessment of individual studies How is potential bias going to be addressed? Is quality examination going to be carried by one or two researchers? How are the quality scores going to be accorded? Are two reviewers going to allocate scores independently and then average them? Are studies going to be excluded based on quality rating? Data synthesis 'A plot of the total number of publications and number of each type of publication over the study period will be generated' -how are you going to plot these numbers? Is this graphic or statistical? General comments There is need to go through the whole manuscript and correct some spellings and a bit of grammar
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GENERAL COMMENTS
Does not seem to be a medical research paper, but more a working tool/ guideline for future research. Does need significant revision of language and grammar.
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GENERAL COMMENTS
This is an important topic. I did a quick pubmed search of "ghana" and "cervical cancer" and got more than 60 publications, so from a feasibility perspective there is probably enough literature to do this review. Important goals include identifying holes in current research efforts, estimating human resources efforts, and mapping partners and collaborations. These are worthy goals.
In the introduction, I think more focus on existing summary literature from Ghana and relevant global health/policy or Africa region literature would be helpful. The databases to be searched are adequate, but methods for gathering and assessing "other grey literature" are incompletely defined.
Selection process -this is where bias can be introduced, so more specific criteria for inclusion or exclusion would be helpful. Also, how will authors deal with data which may only exist in abstract not full text form? I suspect there will be a lot of this.
OUtcomes and data analysis process -from my review of the 60+ articles on Pubmed on Ghana/cervical cancer, I am struck by the fact that most of these are qualitative. It is not clear to me if the authors have a solid qualitative data analysis plan, and I think that is going to be critical here.
Also "Major Data Items" could be more specific -what does "extent of collaboration" mean, and how will that be assessed, for example?
In terms of quantitative data that might be collected, what are the anticipated data elements that authors will be looking forscreening rates, followup care rates, HPV prevalence rates ,that sort of thing?
Under expected outcomes, I totally agree with authors that mapping gaps in area of study is critical and very important. However, can the authors give us some idea of how they conceptualize the field of HPV and cervical cancer? What scheme or disciplinary taxonomy will be used to categorize research efforts so that we can know where such efforts are distributed, and where they might be missing.
Not all elements of the PRISMA checklist are included in the protocol. In particular some of them are very important, like 15a-c, planned quantitative and qualitative synthesis, and should be addressed in more detail in the protocol. Search Strategy COM Nothing systematic has been mention here. Authors need to have a well thought out search strategy for at least one database. As it is right now, there is no search strategy. There is no mention of how the different databases will be search, for example, Cochrane, requires searching via the Cochrane Library using MeSH terms and qualifiers. There is need to use truncation commands (root word) and proximity operators in your search strategies. Citation and reference tracking are also good sources of finding relevant studies. What techniques are to be used in the online databases searchsuch as free-text synonyms etc? RES: A search strategy has been extensively modified and that for PubMed have been provided as example. The search for the other databases will be conducted according to the specific procedure for each of the databases, including the specific truncation commands, proximity operators etc. This will be reported fully after the review is completed in the related publication. However, citation and reference tracking will not be used for this review, since it is not likely to make any difference in the number of relevant study to be identified for the review. [Lines 168 to 196] Study records Selection process COM Include reviewers' initials in the narrative, eg, 'merging of the results of the database searches will be done and two independently working researchers (AAK and EDD). There is no mention of a full-text screening form (which should be available) to enable readers to see the criteria used in selecting studies: RES: This has been mentioned, [Lines 200, 204 and 227] .
COM How many independent researchers are going to be merging the results from the database searches? RES: An online Zotero account will be used and reviewed by the two independent researchers and a third reviewer when disagreement are not resolved by the researchers. [Line 203] COM How are disagreements and other issues pertaining to the screening process going to be resolved? There is need for a third independent reviewer will mediate the discussions. RES: These have been indicated as suggested. .
COM Dates and related activities -This work plan is not necessary to be included in the manuscript. I suggest the authors remove it.
RES: This has been removed COM Risk of bias and quality assessment of individual studies -How is potential bias going to be addressed? RES: This potential bias will be identified and the differences in the studies included in generated or synthesis specific information will be reported to define the limits thereof. .
COM Is quality examination going to be carried by one or two researchers? RES: This will carried out by the two and disagreements resolved as indicated earlier. .
COM How are the quality scores going to be accorded? Are two reviewers going to allocate scores independently and then average them? RES: The two researchers (AKA and EDD) will independently allocate the scores and an average will be determined. COM Are studies going to be excluded based on quality rating? COM Since the focus of the review is to look at the spectrum of research on cervical cancer and HPV in Ghana and that they may not be a deluge of such studies, No study will be exclude due to quality. However, the quality of the study will be indicated. [Lines 293-296].
Data synthesis COM 'A plot of the total number of publications and number of each type of publication over the study period will be generated' -how are you going to plot these numbers? Is this graphic or statistical? RES: This will be done graphically General comments COM There is need to go through the whole manuscript and correct some spellings and a bit of grammar RES: Conducted as suggested.
Reviewer: 2 Reviewer Name: Benny Kirschner COM Does not seem to be a medical research paper, but more a working tool/ guideline for future research. Does need significant revision of language and grammar. RES: Conducted as suggested.
Reviewer: 3 Reviewer Name: Peter Rohloff COM This is an important topic. I did a quick pubmed search of "ghana" and "cervical cancer" and got more than 60 publications, so from a feasibility perspective there is probably enough literature to do this review. Important goals include identifying holes in current research efforts, estimating human resources efforts, and mapping partners and collaborations. These are worthy goals. RES: We thank the reviewer for the kind comments COM In the introduction, I think more focus on existing summary literature from Ghana and relevant global health/policy or Africa region literature would be helpful. The reference to Australia seems somewhat arbitrary. What about recent WHO guidelines, for example, on HPV screening in LMICs and what effect those are having in the AFR region? The framing could be more specific and less general. RES: Although the PRISMA guideline indicated to provide a rational, with little background, we have included a short summary literature on cervical cancer. A full summary literature will be provided in the publication of the review when it is conducted. The Australian example was to indicate one of the most recent use of systematic review to inform policy change, which implies the intension to inform policy in Ghana by this review meets global standard practice. COM The databases to be searched are adequate, but methods for gathering and assessing "other grey literature" are incompletely defined. RES: Methods for gathering and assessing grey literature have been included. .
COM Selection process -this is where bias can be introduced, so more specific criteria for inclusion or exclusion would be helpful. Also, how will authors deal with data which may only exist in abstract not full text form? I suspect there will be a lot of this. RES: The eligibility criteria have been expanded to 13 items and these will apply in the selection of relevant records. Abstracts which meet the eligibility criteria will be included in the review. [Lines 119, [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] .
COM OUtcomes and data analysis process -from my review of the 60+ articles on Pubmed on Ghana/cervical cancer, I am struck by the fact that most of these are qualitative. It is not clear to me if the authors have a solid qualitative data analysis plan, and I think that is going to be critical here. RES: The thematic qualitative data analysis will be employed in this review. A detail description is provided, [Lines 314-329].
COM Also "Major Data Items" could be more specific -what does "extent of collaboration" mean, and how will that be assessed, for example? RES: These haven been modified and the examples now read, 'Proportion of studies which involved internal and external collaboration' and "Proportion of studies which reported of Ethical conduct". Additional information have been provide to make it more specific. [Lines 244-260].
COM In terms of quantitative data that might be collected, what are the anticipated data elements that authors will be looking for -screening rates, follow-up care rates, HPV prevalence rates ,that sort of thing? RES: The data elements that will be looked for in the data extraction are presented as Age at diagnosed with cervical cancer; Age-specific cervical cancer and lesion prevalence; Agespecific HPV prevalence (indicate participants); Approach to cervical cancer prevention 
